OBJECTIVE: While >20% of patients presenting to the cardiac catheterization laboratory with angina have no obstructive coronary artery disease (CAD), a majority (77%) have an occult coronary abnormality (endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB)). There are little data regarding the ability of noninvasive stress testing to identify these occult abnormalities in patients with angina in the absence of obstructive CAD. METHODS: We retrospectively evaluated 155 patients (76.7% women) with angina and no obstructive CAD who underwent stress echocardiography and/or electrocardiography before angiography. We evaluated Duke treadmill score, heart rate recovery (HRR), metabolic equivalents, and blood pressure response. During angiography, patients underwent invasive testing for endothelial dysfunction (decrease in epicardial coronary artery diameter >20% after intracoronary acetylcholine), MVD (index of microcirculatory resistance ≥25), and intravascular ultrasound for the presence of an MB. RESULTS: Stress echocardiography and electrocardiography were positive in 58 (43.6%) and 57 (36.7%) patients, respectively. Endothelial dysfunction was present in 96 (64%), MVD in 32 (20.6%), and an MB in 83 (53.9%). On multivariable logistic regression, stress echo was not associated with any abnormality, while stress ECG was associated with endothelial dysfunction. An abnormal HRR was associated with endothelial dysfunction and MVD, but not an MB. CONCLUSION: Conventional stress testing is insufficient for identifying occult coronary abnormalities that are frequently present in patients with angina in the absence of obstructive CAD. A normal stress test does not rule out a non-obstructive coronary etiology of angina, nor does it negate the need for comprehensive invasive testing.
OBJECTIVE: While >20% of patients presenting to the cardiac catheterization laboratory with angina have no obstructive coronary artery disease (CAD), a majority (77%) have an occult coronary abnormality (endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB)). There are little data regarding the ability of noninvasive stress testing to identify these occult abnormalities in patients with angina in the absence of obstructive CAD. METHODS: We retrospectively evaluated 155 patients (76.7% women) with angina and no obstructive CAD who underwent stress echocardiography and/or electrocardiography before angiography. We evaluated Duke treadmill score, heart rate recovery (HRR), metabolic equivalents, and blood pressure response. During angiography, patients underwent invasive testing for endothelial dysfunction (decrease in epicardial coronary artery diameter >20% after intracoronary acetylcholine), MVD (index of microcirculatory resistance ≥25), and intravascular ultrasound for the presence of an MB. RESULTS: Stress echocardiography and electrocardiography were positive in 58 (43.6%) and 57 (36.7%) patients, respectively. Endothelial dysfunction was present in 96 (64%), MVD in 32 (20.6%), and an MB in 83 (53.9%). On multivariable logistic regression, stress echo was not associated with any abnormality, while stress ECG was associated with endothelial dysfunction. An abnormal HRR was associated with endothelial dysfunction and MVD, but not an MB. CONCLUSION: Conventional stress testing is insufficient for identifying occult coronary abnormalities that are frequently present in patients with angina in the absence of obstructive CAD. A normal stress test does not rule out a non-obstructive coronary etiology of angina, nor does it negate the need for comprehensive invasive testing.
Authors: Morton J Kern; Amir Lerman; Jan-Willen Bech; Bernard De Bruyne; Eric Eeckhout; William F Fearon; Stuart T Higano; Michael J Lim; Martijn Meuwissen; Jan J Piek; Nico H J Pijls; Maria Siebes; Jos A E Spaan Journal: Circulation Date: 2006-08-28 Impact factor: 29.690
Authors: Patricia A Pellikka; Sherif F Nagueh; Abdou A Elhendy; Cathryn A Kuehl; Stephen G Sawada Journal: J Am Soc Echocardiogr Date: 2007-09 Impact factor: 5.251
Authors: Oscar C Marroquin; Richard Holubkov; Daniel Edmundowicz; Cheryl Rickens; Gerald Pohost; Steven Buchthal; Carl J Pepine; George Sopko; Robert C Sembrat; Carolyn Cidis Meltzer; Steven E Reis Journal: Am Heart J Date: 2003-04 Impact factor: 4.749
Authors: Peter Ong; Paolo G Camici; John F Beltrame; Filippo Crea; Hiroaki Shimokawa; Udo Sechtem; Juan Carlos Kaski; C Noel Bairey Merz Journal: Int J Cardiol Date: 2017-09-08 Impact factor: 4.164
Authors: R Gianrossi; R Detrano; D Mulvihill; K Lehmann; P Dubach; A Colombo; D McArthur; V Froelicher Journal: Circulation Date: 1989-07 Impact factor: 29.690
Authors: Martha Gulati; Rhonda M Cooper-DeHoff; Candace McClure; B Delia Johnson; Leslee J Shaw; Eileen M Handberg; Issam Zineh; Sheryl F Kelsey; Morton F Arnsdorf; Henry R Black; Carl J Pepine; C Noel Bairey Merz Journal: Arch Intern Med Date: 2009-05-11
Authors: Joo Myung Lee; Jamie Layland; Ji-Hyun Jung; Hyun-Jung Lee; Mauro Echavarria-Pinto; Stuart Watkins; Andy S Yong; Joon-Hyung Doh; Chang-Wook Nam; Eun-Seok Shin; Bon-Kwon Koo; Martin K Ng; Javier Escaned; William F Fearon; Keith G Oldroyd Journal: Circ Cardiovasc Interv Date: 2015-11 Impact factor: 6.546
Authors: Lasse Jespersen; Steen Z Abildstrom; Anders Hvelplund; Jan K Madsen; Soren Galatius; Frants Pedersen; Soren Hojberg; Eva Prescott Journal: PLoS One Date: 2014-04-04 Impact factor: 3.240
Authors: Nouradden N Aljaber; Shanei A Shanei; Sultan Abdulwadoud Alshoabi; Kamal D Alsultan; Moawia B Gameraddin; Khaled M Al-Sayaghi Journal: J Family Med Prim Care Date: 2020-05-31
Authors: Vedant S Pargaonkar; Justin H Lee; Eric K H Chow; Takeshi Nishi; Robyn L Ball; Yuhei Kobayashi; Takumi Kimura; David P Lee; Marcia L Stefanick; William F Fearon; Alan C Yeung; Jennifer A Tremmel Journal: Circ Cardiovasc Interv Date: 2020-04-13 Impact factor: 7.514
Authors: Niya Mileva; Sakura Nagumo; Takuya Mizukami; Jeroen Sonck; Colin Berry; Emanuele Gallinoro; Giovanni Monizzi; Alessandro Candreva; Daniel Munhoz; Dobrin Vassilev; Martin Penicka; Emanuele Barbato; Bernard De Bruyne; Carlos Collet Journal: J Am Heart Assoc Date: 2022-03-18 Impact factor: 6.106